|
Our senior management is a dedicated team
of
highly qualified professionals with global experience in pioneering research,
new technology commercialization, operational excellence, pharmaceutical development,
regulatory pathways, quality control implementation & entrepreneurship.
Ratner BioMedical
Inc.'s technologies
bridge across disciplines of materials
science, engineering, modern biology
and medicine.
|
 |
J. K. Nair, MS, MBA
President & CEO
Jayakrishnan Krishnan (J.K.) Nair has experience in
bringing medical devices to emerging markets, as well as in
managing large projects and engaging in research for leading
technology entities such as Microsoft, NASA Jet Propulsion Labs,
and IBM. He is also a successful real estate entrepreneur in the
Puget Sound area. During the six+ years he worked for Microsoft,
he managed global teams of more than two dozen engineers,
led extensive product usability studies, designed user training & competitive
evaluations for new technologies, and has also led strategic
negotiations for large scale site-licenses. His publication
record on fault tolerance in NASA space applications and
robotics makes him an “Erdos #2”. He is the recipient of many
awards and honors for academic and professional excellence (such
as the National Innovation Potential Award,
Microsoft IT Pro Award etc), and has patented a
speech-recognition-based medical device that enables paralyzed
patients to vocally control all essential devices, thereby
increasing their physical independence. He holds a B.Tech in
Electronics & Communications Engineering (distinction) from the
University of Kerala, India, an MS in Computer Engineering
(honors) from the University of Massachusetts-Amherst, and an
MBA in Technology Management (honors) from the University of
Washington (Foster School of Business). |
 |
Jelle Kylstra, MD, MBA
VP, Clinical and Regulatory Affairs
Dr. Jelle W. Kylstra brings nearly two decades of clinical drug
and medical device development experience to RBI, primarily in
oncology, hematology, metabolic and infectious disease. He
joined Ratner from RITA Medical Systems in 2009, wherein as Vice
President and Medical Director, he led the development and
registration of a number of interventional oncology devices and
drug-device combination products. Prior to that, he was Senior
Medical Director at Dendreon Corporation, where he designed and
executed the Phase 2 and Phase 3 clinical trials for Provenge,
the world's first cellular immunotherapy for prostate cancer.
Dr. Kylstra started his industry career with Procter and Gamble,
where he developed Actonel for osteoporosis. Dr. Kylstra holds
an MD degree from the University of Amsterdam, Netherlands, and
an MBA from Northwestern University's Kellogg School of
Management, Evanston, Illinois. During his hematology research
fellowship in the 1980s, he characterized the performance of low
molecular weight heparinoids, and later successfully introduced
in the clinic. He also serves as editorial reviewer for journals
such as the American Journal of Transplantation. |
 |
Arch Holder
VP, Operations
Arch C. Holder received his Bachelor of Science degree from
Texas State University in Industrial Technology. Arch has
extensive experience as a corporate resource for resolving
‘Critical to Success Problems’ with major industry leaders such
as IBM Corporation, Dell, Inc., GVC, BCM Advanced Research and
Microsoft. During his tenure with IBM he held a position on the
original Personal Computer team and was selected as a key
contributor responsible for building IBM’s Industrial Sector
Division, which is today’s Global Services. In this role he
spearheaded engagements with Fortune 500 companies ranging from
High-Tech Electronics, Medical, Aerospace, Defense and Food &
Beverage. Customers included Baxter Edwards CVS, Johnson &
Johnson, Abbott Labs, Lockheed Martin, Del Monte, and RJR
Nabisco. Arch accomplished IBM’s Internal Management training
and secured multiple certifications in Quality, Six Sigma Black
Belt, Environmental, Hazardous Material Handling and Safety. He
was the recipient of an IBM Excellence Award for corporate
strategic planning and execution. At Dell Arch implemented
quality systems and increased production more than threefold for
all PC products. Microsoft contracted Arch to lead manufacturing
and operations for the launch of Xbox, which involved B2B
operations in this multi-national business venture. Microsoft
hired Arch to establish business practices for Contract
Management and Compliance; he was a stakeholder to assure
Sarbanes-Oxley compliance. As Senior Build Program Manager, he
was responsible for implementing operations, regulatory and
environmental compliance for the manufacturing of Microsoft’s
Surface Computing product; this was a global effort across the
United States, Asia and Europe. He is a Senior Member within
American Society for Quality and has held a series of leadership
positions within the Austin, TX and Seattle, WA chapters. |
 |
Cindy Webb, CPA
Chief Accounts Officer
Cindy Webb is a licensed CPA in the State of Washington. She
received her B.A. degree from the University of Washington with
an emphasis in accounting. She practiced public accounting with
Deloitte & Touche and then held various corporate accounting
positions within PACCAR. Most recently, her time has been spent
as a consultant for startup businesses in Hertogs & Webb, LLC.
Cindy is proficient at implementing QuickBooks, establishing
accounting processes, producing monthly financial statements and
preparing tax returns. |
 |
Chris Rathe
Chief Strategic Advisor
Chris Rathe is the CEO and Co-Founder of PriTest Inc. (www.pritest.com), a medical technology company focused on commercializing new tuberculosis detection techniques. He has also co-founded Metacode Technologies Inc., a San Francisco content management software firm. As COO/CFO Chris helped to commercialize innovative technology with million dollar sales, and led the company through a $150M merger with industry leader Interwoven Inc. During his tenure at Metacode, Chris oversaw strategic business planning, fund raising, intellectual property matters, physical and IP security, legal and licensing agreements, and administration of daily operations. He has also co-founded Bio Research Laboratories Inc. (BRL), a Redmond, Washington biotechnology company, managing BRL’s analytical laboratory business. Chris has a B.S. in business administration and finance law from Portland State University.
|
|
